Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
14
Published: Jan. 4, 2024
Introduction:
Attention
deficit/hyperactivity
disorder
(ADHD)
is
a
common
neurodevelopmental
characterized
by
hyperactivity,
inattention,
and
impulsivity
that
often
persist
until
adulthood.
Frequent
comorbid
disorders
accompany
ADHD
two
thirds
of
children
diagnosed
with
also
suffer
from
behavioural
alteration
sensory
processing.
We
recently
the
comorbidity
between
ADHD-like
symptoms
pain
sensitisation
in
pharmacological
mouse
model
ADHD,
we
demonstrated
implication
anterior
cingulate
cortex
posterior
insula.
However,
few
studies
have
explored
causal
mechanisms
underlying
interactions
pain.
The
inflammatory
has
been
suggested
but
signalling
pathways
involved
not
explored.
Methods:
investigated
roles
purinergic
signalling,
at
crossroad
neuroinflammatory
pathways,
using
transgenic
line
carries
total
deletion
P2X4
receptor.
Results:
prevents
hyperactivity
ADHD.
In
contrast,
absence
lowered
thermal
thresholds
sham
conditions
did
affect
sensitization
conditions.
further
analysed
microglia
reactivity
expression
markers
wild
type
P2X4KO
mice.
Our
results
revealed
limits
same
time
exerts
proinflammatory
effects
Conclusion:
This
dual
role
could
be
responsible
for
differential
noted
on
calls
to
investigate
therapeutic
benefit
targeting
receptor
patients.
Anesthesiology,
Journal Year:
2018,
Volume and Issue:
129(2), P. 343 - 366
Published: Feb. 16, 2018
Abstract
Chronic
pain
is
maintained
in
part
by
central
sensitization,
a
phenomenon
of
synaptic
plasticity,
and
increased
neuronal
responsiveness
pathways
after
painful
insults.
Accumulating
evidence
suggests
that
sensitization
also
driven
neuroinflammation
the
peripheral
nervous
system.
A
characteristic
feature
activation
glial
cells,
such
as
microglia
astrocytes,
spinal
cord
brain,
leading
to
release
proinflammatory
cytokines
chemokines.
Recent
studies
suggest
chemokines
are
powerful
neuromodulators
play
sufficient
role
inducing
hyperalgesia
allodynia
system
administration.
Sustained
increase
promotes
chronic
widespread
affects
multiple
body
sites.
Thus,
drives
via
sensitization.
We
discuss
sex-dependent
glial/immune
signaling
new
therapeutic
approaches
control
for
resolution
pain.
Frontiers in Pharmacology,
Journal Year:
2017,
Volume and Issue:
8
Published: Sept. 25, 2017
Purinergic
signalling,
i.e.
the
role
of
nucleotides
as
extracellular
signalling
molecules,
was
proposed
in
1972.
However,
this
concept
not
well
accepted
until
early
1990's
when
receptor
subtypes
for
purines
and
pyrimidines
were
cloned
characterised,
which
includes
4
P1
(adenosine)
receptor,
7
P2X
ion
channel
receptors
8
P2Y
G
protein-coupled
receptor.
Early
studies
largely
concerned
with
physiology,
pharmacology
biochemistry
purinergic
signalling.
More
recently,
focus
has
been
on
pathophysiology
therapeutic
potential.
There
recognition
use
agonists
treatment
supraventicular
tachycardia
A2A
antagonists
are
promising
Parkinson's
disease.
Clopidogrel,
a
P2Y¬12
antagonist,
is
widely
used
thrombosis
stroke,
blocking
receptor-mediated
platelet
aggregation.
Diquafasol,
long
acting
P2Y¬2
agonist,
being
dry
eye.
P2X3
have
developed
that
orally
bioavailable
stable
vivo
currently
clinical
trials
chronic
cough,
bladder
incontinence,
visceral
pain
hypertension.
Antagonists
to
P2X7
investigated
inflammatory
disorders,
including
neurodegenerative
diseases.
Other
investigations
progress
agents
osteoporosis,
myocardial
infarction,
irritable
bowel
syndrome,
epilepsy,
atherosclerosis,
depression,
autism,
diabetes
cancer.
Pharmaceuticals,
Journal Year:
2025,
Volume and Issue:
18(3), P. 363 - 363
Published: March 4, 2025
Pain,
or
the
ability
to
feel
pain
and
express
unpleasantness
caused
by
peripheral
injuries,
are
functions
of
central
nervous
system.
From
sensory
nerve
terminals
certain
cortical
regions
brain,
activation
related
neural
networks
underlies
process.
Recently,
our
knowledge
has
been
increasing
dramatically,
due
advancement
scientific
approaches.
We
no
longer
see
brain
as
a
random
matrix
for
but,
rather,
we
able
identify
step-by-step
selective
signaling
proteins,
neurons,
that
preferentially
contribute
process
chronic
its
negative
emotions,
like
anxiety
fear.
However,
there
is
still
lacking
effective
drugs
methods
treatment
clinically.
While
first-line
acute
mental
diseases
also
applied
clinical
management
pain,
their
prolonged
usage
always
causes
serious
side
effects.
In
this
short
review,
will
update
summarize
recent
progress
in
field
mainly
focus
on
roles
synaptic
mechanisms
neuropathic
pain.
Furthermore,
potential
drug
targets
(such
plasticity-related
molecules,
ionic
channels,
cytokines,
neuropeptides)
be
discussed
well.
hope
review
can
provide
new,
valuable
insight
into
International Journal of Molecular Sciences,
Journal Year:
2020,
Volume and Issue:
21(10), P. 3440 - 3440
Published: May 13, 2020
Chronic
pain
patients
frequently
develop
and
suffer
from
mental
comorbidities
such
as
depressive
mood,
impaired
cognition,
other
significant
constraints
of
daily
life,
which
can
only
insufficiently
be
overcome
by
medication.
The
emotional
cognitive
components
are
processed
the
medial
prefrontal
cortex,
comprises
anterior
cingulate
prelimbic,
infralimbic
cortex.
All
three
subregions
significantly
affected
chronic
pain:
magnetic
resonance
imaging
has
revealed
gray
matter
loss
in
all
these
areas
conditions.
While
cortex
appears
hyperactive,
regions
show
reduced
activity.
receives
ascending,
nociceptive
input,
but
also
exerts
important
top-down
control
sensation:
its
projections
main
cortical
input
periaqueductal
gray,
is
part
descending
inhibitory
system
at
spinal
level.
A
multitude
neurotransmitter
systems
contributes
to
fine-tuning
local
circuitry,
cholinergic
GABAergic
signaling
particularly
emerging
relevant
affective
processing
within
Accordingly,
factors
distraction,
positive
anticipation
relief
placebo
ameliorate
affecting
mPFC
function,
making
this
area
a
promising
target
region
for
medical
well
psychosocial
interventions
therapy.
Journal of Neuroinflammation,
Journal Year:
2020,
Volume and Issue:
17(1)
Published: May 11, 2020
Abstract
Background
Neuroinflammation
plays
a
vital
role
in
the
development
and
maintenance
of
neuropathic
pain.
Recent
evidence
has
proved
that
bone
marrow
mesenchymal
stem
cells
(BMSCs)
can
inhibit
pain
possess
potent
immunomodulatory
immunosuppressive
properties
via
secreting
variety
bioactive
molecules,
such
as
TNF-α-stimulated
gene
6
protein
(TSG-6).
However,
it
is
unknown
whether
BMSCs
exert
their
analgesic
effect
against
by
TSG-6.
Therefore,
present
study
aimed
to
evaluate
effects
TSG-6
released
from
on
induced
chronic
constriction
injury
(CCI)
rats
explored
possible
underlying
mechanisms
vitro
vivo.
Methods
were
isolated
rat
characterized
flow
cytometry
functional
differentiation.
One
day
after
CCI
surgery,
about
5
×
10
intrathecally
injected
into
spinal
cerebrospinal
fluid.
Behavioral
tests,
including
mechanical
allodynia,
thermal
hyperalgesia,
motor
function,
carried
out
at
1,
3,
5,
7,
14
days
surgery.
Spinal
cords
processed
for
immunohistochemical
analysis
microglial
marker
Iba-1.
The
mRNA
levels
pro-inflammatory
cytokines
(IL-1β,
TNFα,
IL-6)
detected
real-time
RT-PCR
ELISA.
activation
TLR2/MyD88/NF-κB
signaling
pathway
was
evaluated
Western
blot
immunofluorescence
staining.
exogenous
recombinant
CCI-induced
allodynia
heat
hyperalgesia
observed
behavioral
tests.
In
experiments,
primary
cultured
microglia
stimulated
with
TLR2
agonist
Pam3CSK4,
then
co-cultured
or
expression
TLR2,
MyD88,
p-p65
blot.
IL-1β,
IL-6
transfected
TSG-6-specific
shRNA
fluid
vivo
Pam3CSK4-treated
investigate
participated
therapeutic
neuroinflammation.
Results
We
found
ameliorated
intrathecal
injection
BMSCs.
Moreover,
administration
inhibited
neuroinflammation
cord
tissues.
anti-inflammatory
property
attenuated
when
silenced.
also
ipsilateral
dorsal
horn
Meanwhile,
we
effectively
Furthermore,
experiments
showed
downregulated
reduced
production
cytokines,
IL-6,
TNF-α,
treated
specific
Pam3CSK4.
Conclusions
demonstrated
paracrine
mechanism
which
targets
elicit
neuroprotection
sustained
relief
secretion.
Neural Plasticity,
Journal Year:
2022,
Volume and Issue:
2022, P. 1 - 13
Published: Feb. 15, 2022
Chronic
pain
patients
often
develop
mental
disorders,
and
anxiety
disorders
are
common.
We
hypothesize
that
the
comorbid
results
from
an
imbalance
between
reward
antireward
system
due
to
persistent
pain,
which
leads
dysfunction
of
regulatory
system.
In
this
review,
we
will
focus
on
changes
in
neuroplasticity,
especially
neural
circuits,
during
chronic
as
observed
animal
studies.
Several
circuits
within
specific
regions
brain,
including
nucleus
accumbens,
lateral
habenular,
parabrachial
nucleus,
medial
septum,
anterior
cingulate
cortex,
amygdala,
hippocampus,
prefrontal
bed
stria
terminalis,
be
discussed
based
novel
findings
after
chemogenetic
or
optogenetic
manipulation.
believe
these
studies
provide
insights
into
human
conditions
can
guide
clinical
practice.
Pharmaceutics,
Journal Year:
2025,
Volume and Issue:
17(1), P. 44 - 44
Published: Jan. 1, 2025
Background/Objectives:
We
previously
demonstrated
that
the
intranasal
administration
of
cell-penetrating
Tat
peptide-modified
carrier,
PEG-PCL-Tat,
improves
drug
delivery
to
central
nervous
system.
This
study
aimed
evaluate
potential
post-onset
N-acetyl-L-cysteine
(NAC)
combined
with
PEG-PCL-Tat
(NAC/PPT)
for
neuropathic
pain.
Methods:
Neuropathic
pain
was
induced
by
partial
sciatic
nerve
ligation
(PSNL)
in
mice.
Mechanical
allodynia
assessed
using
von
Frey
test
on
days
11–14
post-ligation.
NAC
or
NAC/PPT
intranasally
administered
after
onset.
Western
blotting
and
immunohistochemistry
were
conducted
ionized
calcium-binding
adapter
molecule
1
(Iba-1)
expression
microglial
activation
spinal
cord.
Results:
exacerbated
11
PSNL
The
alone
prevented
exacerbation
but
failed
provide
a
therapeutic
effect
against
In
contrast,
ameliorated
PSNL-induced
tactile
allodynia,
maximum
efficacy
seen
13
14
ligation.
Iba-1
levels
tended
increase
mice
compared
controls.
trend
increased
attenuated
NAC/PPT,
not
alone.
Immunohistochemistry
revealed
an
number
Iba-1-stained
microglia
ipsilateral
cord
mice,
which
significantly
suppressed
NAC/PPT.
Conclusions:
These
results
suggest
ameliorates
mechanical
suppressing
induction
might
be
useful
tool
pharmacological
management